English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech BioTech (Sci&Research)
DETAK by Brawijaya University Researchers detects Heart Disease Early and Accurately
Nov 27, 2020 10:00 HKT
Brawijaya University develops GAD65 Rapid Test Diabetes Screening Kit
Nov 25, 2020 14:00 HKT
中国抗体内地总部建设正式开工
Nov 23, 2020 15:22 HKT
中國抗體內地總部建設正式開工
Nov 23, 2020 15:21 HKT
SinoMab Commenced Construction of its China Headquarters
Nov 23, 2020 15:20 HKT
疫苗科技,中國力量
Nov 20, 2020 22:31 HKT
疫苗科技,中国力量
Nov 20, 2020 22:30 HKT
覆蓋亞太地區的一體化創新腫瘤藥公司德琪醫藥有限公司於香港聯合交易所主板掛牌
Nov 20, 2020 15:16 HKT
Antengene Corporation Successfully Listed on Main Board of SEHK
Nov 20, 2020 15:15 HKT
「格隆汇·大中华区最佳上市公司·2020」评选结果揭晓 中国生物科技服务荣获「2020年抗疫杰出贡献奖」
Nov 17, 2020 18:26 HKT
「格隆滙·大中華區最佳上市公司·2020」評選結果揭曉 中國生物科技服務榮獲「2020年抗疫杰出貢獻獎」
Nov 17, 2020 18:25 HKT
陈力博士受邀参加浦东开放30周年庆祝大会
Nov 13, 2020 09:37 HKT
陳力博士受邀參加浦東開放30周年慶祝大會
Nov 13, 2020 09:36 HKT
Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002
Nov 12, 2020 15:00 HKT
APOLLOMICS(冠科美博)APL-102 I期临床研究获得中国新药临床试验批件
Nov 12, 2020 14:35 HKT
APOLLOMICS(冠科美博)APL-102 I期臨床研究獲得中國新藥臨床試驗批件
Nov 12, 2020 14:29 HKT
BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine
Nov 11, 2020 17:00 HKT
With Two Potential First-in-class Innovative Drugs' Commercialization around the Corner, RemeGen is Expected to Explode upon Listing
Nov 06, 2020 14:56 HKT
APOLLOMICS(冠科美博)完成1.24億美元C輪融資
Nov 06, 2020 12:01 HKT
APOLLOMICS(冠科美博)完成1.24亿美元C轮融资
Nov 06, 2020 12:00 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: